» Articles » PMID: 2728351

Mutation Rate of the Hepadnavirus Genome

Overview
Journal Virology
Specialty Microbiology
Date 1989 Jun 1
PMID 2728351
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

An essential factor for charting the evolution of hepadnaviruses is an estimation of the mutation rate of the virus genome during replication in the host. In order to determine the mutation rate of the hepadnavirus genome under defined experimental conditions, we transfected 10 neonatal woodchucks with an infectious molecular clone of woodchuck hepatitis virus (WHV). By 4 months post-transfection, all 10 animals showed serological evidence for WHV infection. Subsequently, 1 animal became chronically infected and was used for further study. At 16 months post-transfection WHV DNA from serum virions was cloned and the nucleotide sequence of three independent progeny genomes compared directly with that of the input recombinant DNA. Although the consensus nucleotide sequence remained unchanged, we found three differences in individual progeny genomes when compared to the parental genome sequence. Thus, we estimate the mutation rate of the WHV genome to be less than or equal to 2 X 10(-4) base substitutions/site/year. This figure is one to two orders of magnitude lower than the mutation rates previously calculated for the positive- and negative-strand RNA viruses, but is similar to the mutation rate of the gag gene which is the most slowly evolving gene of retroviruses. Therefore, we find that the hepadnavirus genome is relatively stable during replication in host tissues when compared to other viruses that lack polymerase-associated proofreading functions.

Citing Articles

Phylogenetic Analysis and Emerging Drug Resistance against Different Nucleoside Analogues in Hepatitis B Virus Positive Patients.

Gohar M, Rehman I, Ullah A, Khan M, Yasmin H, Ahmad J Microorganisms. 2023; 11(11).

PMID: 38004634 PMC: 10673510. DOI: 10.3390/microorganisms11112622.


HBV precore G1896A mutation promotes growth of hepatocellular carcinoma cells by activating ERK/MAPK pathway.

Zhao B, Qiao H, Zhao Y, Gao Z, Wang W, Cui Y Virol Sin. 2023; 38(5):680-689.

PMID: 37331658 PMC: 10590694. DOI: 10.1016/j.virs.2023.06.004.


Association of Pre-S/S and Polymerase Mutations with Acute and Chronic Hepatitis B Virus Infections in Patients from Rio de Janeiro, Brazil.

de Almeida Ribeiro C, Martinelli K, da Motta de Mello V, Spitz N, Araujo O, Lewis-Ximenez L Viruses. 2022; 14(7).

PMID: 35891356 PMC: 9315576. DOI: 10.3390/v14071375.


Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements.

Perisetti A, Goyal H, Yendala R, Thandassery R, Giorgakis E World J Gastroenterol. 2021; 27(24):3466-3482.

PMID: 34239263 PMC: 8240056. DOI: 10.3748/wjg.v27.i24.3466.


Conservative Evolution of Hepatitis B Virus Precore and Core Gene During Immune Tolerant Phase in Intrafamilial Transmission.

Luo Y, Zhang L, Dai Y, Hu Y, Xu B, Zhou Y Virol Sin. 2020; 35(4):388-397.

PMID: 32124248 PMC: 7462953. DOI: 10.1007/s12250-020-00194-6.